The survival time of cervical cancer metastasis to lungs is related to the patient’s physical quality and the severity of the disease, which can not be accurately judged, and the survival time can be prolonged and the prognosis of the disease can be improved through treatment. Lung metastasis of cervical cancer often suggests that it enters the advanced stage of cancer with bad prognosis and needs active treatment. Targeted therapy, radiotherapy, chemotherapy and other comprehensive treatments can be chosen, through which tumor lesions can be shrunk, tumor proliferation and metastasis can be inhibited, life quality of patients can be improved, and survival time of patients can be prolonged. Commonly used chemotherapeutic drugs include cytarabine, fluorouracil, paclitaxel and so on; targeted drugs include trastuzumab, bevacizumab and so on. The drugs are recommended to be used in strict compliance with the doctor’s instructions, the occurrence of adverse reactions such as dizziness, diarrhea and other timely medical treatment, drug allergy is prohibited.